Health-care Provision and Health-care Reform in Post-Mao China
April 2014
- Testimony
- Testimony by CFR fellows and experts before Congress.
More on:
An effective strategy to engage China's health-care sector requires the U.S. government to continue promoting business opportunities for U.S. biopharmaceutical firms, hospital groups, and insurance companies, CFR Senior Fellow for Global Health Yanzhong Huang tells the U.S.-China Economic and Security Review Commission. In the meantime, it is also important for the U.S. government and companies to demonstrate the willingness to work with China in addressing health issues of their immediate concern.
More on: